Breast Cancer Liquid Biopsy Market Size, Share & Trends Report

Breast Cancer Liquid Biopsy Market Size, Share & Trends Analysis Report By Circulating Biomarkers (Circulating Tumor Cells, Circulating Cell-free DNA, Extracellular Vesicles), By Application, By Region, And Segment Forecasts, 2022 - 2030

  • Report ID: GVR-4-68039-991-9
  • Number of Pages: 130
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2020
  • Industry: Healthcare

Table of Contents

Chapter 1 Methodology and Scope
                   1.1 Market Segmentation
                       1.1.1 Estimates And Forecast Timeline
                   1.2 Research Methodology
                   1.3 Information Procurement
                       1.3.1 Purchased Database
                       1.3.2 Secondary Sources
                       1.3.3 Primary Research
                       1.3.4 Details Of Primary Research
                   1.4 Information Or Data Analysis
                       1.4.1 Data Analysis Models
                   1.5 Market Formulation & Validation
                   1.6 Model Details
                       1.6.1 Commodity Flow Analysis
                           1.6.1.1 Approach 1: Commodity Flow Approach
                           1.6.1.2 Approach 2: Country - Wise Market Estimation Using Bottom - Up Approach
                   1.7 Global Market: Cagr Calculation
                   1.8 Research Assumptions
                   1.9 List Of Secondary Sources
                   1.10 List Of Primary Sources
                   1.11 Objectives
                       1.11.1 Objective 1:
                       1.11.2 Objective 2:
                   1.12 List of Abbreviations
Chapter 2 Executive Summary
                   2.1 Market Summary
Chapter 3 Breast Cancer Liquid Biopsy Market Variables, Trends, & Scope
                   3.1 Breast Cancer Liquid Biopsy Market Lineage Outlook
                       3.1.1 Parent Market Outlook
                       3.1.2 Ancillary Market Outlook - In Vitro Diagnostics (Ivd) Market
                   3.2 Penetration And Growth Prospect Mapping
                   3.3 Market Dynamics
                   3.4 Market Driver Analysis
                       3.4.1 Increasing Prevalence Of Breast Cancer
                       3.4.2 Increasing Adoption Of Liquid Biopsies In Cancer Diagnosis
                       3.4.3 Need To Provide Early Diagnosis And Treatment
                   3.5 Market Restraint Analysis
                       3.5.1 High Cost Associated With Breast Cancer Liquid Biopsy Tests
                       3.5.2 Regulatory & Reimbursement Hurdles
                   3.6 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
                   3.7 Porter’s Five Forces Analysis
Chapter 4 Breast Cancer Liquid Biopsy Market - Segment Analysis, By Circulating Biomarkers, 2018 - 2030 (USD Million)
                   4.1 Breast Cancer Liquid Biopsy Market: Circulating Biomarkers Movement Analysis
                       4.1.1 Circulating Tumor Cells (Ctcs)
                           4.1.1.1 Circulating Tumor Cells (Ctcs) Market Estimates And Forecast, 2018 - 2030 (USD Million)
                       4.1.2 Circulating Cell - Free Dna (Cfdna)
                           4.1.2.1 Circulating Cell - Free Dna (Cfdna) Market Estimates And Forecast, 2018 - 2030 (USD Million)
                       4.1.3 Extracellular Vesicles (Evs)
                           4.1.3.1 Extracellular Vesicles (Evs) Market Estimates And Forecast, 2018 - 2030 (USD Million)
                       4.1.4 Other Circulating Biomarkers
                           4.1.4.1 Other Circulating Biomarkers Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 5 Breast Cancer Liquid Biopsy Market - Segment Analysis, By Application, 2018 - 2030 (USD Million)
                   5.1 Breast Cancer Liquid Biopsy Market: Application Movement Analysis
                       5.1.1 Early Detection/Screening
                           5.1.1.1 Early Detection/Screening Market Estimates And Forecast, 2018 - 2030 (USD Million)
                       5.1.2 Diagnosis
                           5.1.2.1 Diagnosis Market Estimates And Forecast, 2018 - 2030 (USD Million)
                       5.1.3 Treatment Selection
                           5.1.3.1 Treatment Selection Market Estimates And Forecast, 2018 - 2030 (USD Million)
                       5.1.4 Monitoring
                           5.1.4.1 Monitoring Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 6 Breast Cancer Liquid Biopsy Market - Segment Analysis, by Region, 2018 - 2030 (USD Million)
                   6.1 Breast Cancer Liquid Biopsy Market: Regional Movement Analysis
                   6.2 North America
                       6.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
                       6.2.2 U.S.
                           6.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
                       6.2.3 Canada
                           6.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
                   6.3 Europe
                       6.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
                       6.3.2 U.K.
                           6.3.2.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
                       6.3.3 Germany
                           6.3.3.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
                       6.3.4 France
                           6.3.4.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
                       6.3.5 Italy
                           6.3.5.1 Italy Breast Cancer Liquid Biopsy Market, 2018 - 2030 (USD Million)
                       6.3.6 Spain
                           6.3.6.1 Spain Breast Cancer Liquid Biopsy Market, 2018 - 2030 (USD Million)
                   6.4 Asia Pacific
                       6.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
                       6.4.2 Japan
                           6.4.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
                       6.4.3 China
                           6.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
                       6.4.4 India
                           6.4.4.1 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
                       6.4.4 Australia
                           6.4.4.1 Australia Breast Cancer Liquid Biopsy Market, 2018 - 2030 (USD Million)
                       6.4.5 South Korea
                           6.4.5.1 South Korea Breast Cancer Liquid Biopsy Market, 2018 - 2030 (USD Million)
                   6.5 Latin America
                       6.5.1 Latin America Breast Cancer Liquid Biopsy Market, 2018 - 2030 (USD Million)
                       6.5.2 Brazil
                           6.5.2.1 Brazil Breast Cancer Liquid Biopsy Market, 2018 - 2030 (USD Million)
                       6.5.3 Mexico
                           6.5.3.1 Mexico Breast Cancer Liquid Biopsy Market, 2018 - 2030 (USD Million)
                       6.5.3 Argentina
                           6.5.4.1 Argentina Breast Cancer Liquid Biopsy Market, 2018 - 2030 (USD Million)
                   6.6 Mea
                       6.6.1 Mea Breast Cancer Liquid Biopsy Market, 2018 - 2030 (USD Million)
                       6.6.2 South Africa
                           6.6.2.1 South Africa Breast Cancer Liquid Biopsy Market, 2018 - 2030 (USD Million)
                       6.6.3 Saudi Arabia
                           6.6.3.1 Saudi Arabia Breast Cancer Liquid Biopsy Market, 2018 - 2030 (USD Million)
                       6.6.4 UAE
                           6.6.4.1 UAE Breast Cancer Liquid Biopsy Market, 2018 - 2030 (USD Million)
Chapter 7 Breast Cancer Liquid Biopsy Market: Competitive Analysis
                   7.1 Recent developments and impact analysis, by key market participants
                       7.1.1 Ansoff Matrix
                       7.1.2 Major Deals And Strategic Alliances Analysis
                           7.1.2.1 Market Expansion
                           7.1.2.2 Product Launch
                           7.1.2.3 Acquisition
                           7.1.2.4 Partnerships And Collaborations
                   7.2 Company Categorization
                       7.2.1 Innovators
                       7.2.2 Market Leaders
                   7.3 Vendor Landscape
                       7.3.1 List Of Key Distributors And Channel Partners
                       7.3.2 Key Customers
                       7.3.3 Key Company Market Share Analysis, 2021
                   7.4 Public Companies
                       7.4.1 Company Market Position Analysis
                       7.4.2 Heat Map Analysis
                       7.4.3 Regional Network Map
                       7.4.4 Competitive Dashboard Analysis
                           7.4.4.1 Market Differentiators
                   7.5 Private Companies
                       7.5.1 List Of Key Emerging Companies
                       7.5.2 Heat Map Analysis
                       7.5.3 Regional Network Map
Chapter 8 Company Profiles
                   8.1 The Menarini Group
                       8.1.1 Company Overview
                       8.1.2 Financial Performance
                       8.1.3 Product Benchmarking
                       8.1.4 Strategic Initiatives
                   8.2 NeoGenomics Laboratories
                       8.2.1 Company Overview
                       8.2.2 Financial Performance
                       8.2.3 Product Benchmarking
                       8.2.4 Strategic Initiatives
                   8.3 F. Hoffmann - La Roche Ltd.,
                       8.3.1 Company Overview
                       8.3.2 Financial Performance
                       8.3.2 Product Benchmarking
                       8.3.4 Strategic Initiatives
                   8.4 Myriad Genetics, Inc.
                       8.4.1 Company Overview
                       8.4.2 Financial Performance
                       8.4.3 Product Benchmarking
                       8.4.4 Strategic Initiatives
                   8.5 Thermo Fisher Scientific, Inc.
                       8.5.1 Company Overview
                       8.5.2 Financial Performance
                       8.5.3 Product Benchmarking
                       8.5.4 Strategic Initiatives
                   8.6 QIAGEN
                       8.6.1 Company Overview
                       8.6.2 Financial Performance
                       8.6.2 Product Benchmarking
                       8.6.4 Strategic Initiatives
                   8.7 Biocept, Inc.
                       8.7.1 Company Overview
                       8.7.2 Financial Performance
                       8.7.3 Product Benchmarking
                       8.7.4 Strategic Initiatives
                   8.8 Sysmex Corporation
                       8.8.1 Company Overview
                       8.8.2 Financial Performance
                       8.8.3 Product Benchmarking
                       8.9.4 Strategic Initiatives
                   8.9 Fluxion Biosciences, Inc.
                       8.9.1 Company Overview
                       8.9.2 Financial Performance
                       8.9.3 Product Benchmarking
                       8.9.4 Strategic Initiatives
                   8.10 Epic Sciences, Inc.
                       8.9.1 Company Overview
                       8.9.2 Financial Performance
                       8.9.3 Product Benchmarking
                       8.9.4 Strategic Initiatives


List of Tables

TABLE 1 List of secondary sources
TABLE 2 List of abbreviations
TABLE 3 Regulatory framework
TABLE 4 Global breast cancer liquid biopsy market, by region, 2018 - 2030 (USD Million)
TABLE 5 Global breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 6 Global breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 7 North America breast cancer liquid biopsy market, by country, 2018 - 2030 (USD Million)
TABLE 8 North America breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 9 North America breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 10 U.S. breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 11 U.S. breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 12 Canada breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 13 Canada breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 14 Europe breast cancer liquid biopsy market, by country, 2018 - 2030 (USD Million)
TABLE 15 Europe breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 16 Europe breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 17 U.K. breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 18 U.K. breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 19 Germany breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 20 Germany breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 21 Spain breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 22 Spain breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 23 France breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 24 France breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 25 Italy breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 26 Italy breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 27 Asia Pacific breast cancer liquid biopsy market, by country, 2018 - 2030 (USD Million)
TABLE 28 Asia Pacific breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 29 Asia Pacific breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 30 Japan breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 31 Japan breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 32 China breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 33 China breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 34 India market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 35 India breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 36 Australia market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 37 Australia breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 38 South Korea market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 39 South Korea breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 40 South Korea breast cancer liquid biopsy market, by product circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 41 Latin America breast cancer liquid biopsy market, by country, 2018 - 2030 (USD Million)
TABLE 42 Latin America breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 43 Latin America breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 44 Brazil breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 45 Brazil breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 46 Mexico breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 47 Mexico breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 48 Argentina breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 49 Argentina breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 50 MEA breast cancer liquid biopsy market, by country, 2018 - 2030 (USD Million)
TABLE 51 MEA breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 52 MEA breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 53 South Africa breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 54 South Africa breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 55 Saudi Arabia breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 56 Saudi Arabia breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)
TABLE 57 UAE breast cancer liquid biopsy market, by circulating biomarkers, 2018 - 2030 (USD Million)
TABLE 58 UAE breast cancer liquid biopsy market, by application, 2018 - 2030 (USD Million)


List of Figures

FIG. 1 Breast cancer liquid biopsy market segmentation
FIG. 2 Market research process
FIG. 3 Data triangulation techniques
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value - chain - based sizing & forecasting
FIG. 7 QFD modeling for market share assessment
FIG. 8 Market formulation & validation
FIG. 9 Breast cancer liquid biopsy market snapshot
FIG. 10 Penetration and growth prospect mapping for application, 2021 (USD Million)
FIG. 11 Market Dynamics
FIG. 12 Breast cancer liquid biopsy market driver impact
FIG. 13 Enzymes in the diagnosis of diseases
FIG. 14 Common applications of enzymes in pathology
FIG. 15 Breast cancer liquid biopsy market restraint impact
FIG. 16 Porter’s five forces analysis
FIG. 17 Breast cancer liquid biopsy market: Circulating biomarkers outlook and key takeaways
FIG. 18 Circulating tumor Cells (CTCs) market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 19 Circulating cell - free DNA (cfDNA) market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 20 Extracellular Vesicles (EVs) market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 21 Others circulating biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 22 Breast cancer liquid biopsy market: Application outlook and key takeaways
FIG. 23 Breast cancer liquid biopsy market: Application movement analysis
FIG. 24 Early detection/screening market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 25 Diagnosis market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 26 Treatment selection market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 27 Monitoring market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 28 Breast cancer liquid biopsy Market: Regional outlook and key takeaways
FIG. 29 Breast cancer liquid biopsy: Regional movement analysis
FIG. 30 North America
FIG. 31 North America. market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 32 U.S.
FIG. 33 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 34 Canada
FIG. 35 Canada market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 36 Europe
FIG. 37 Europe market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 38 UK
FIG. 39 UK market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 40 Germany
FIG. 41 Germany market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 42 France
FIG. 43 France market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 44 Spain
FIG. 45 Spain market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 46 Italy
FIG. 47 Italy market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 48 Asia Pacific
FIG. 49 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 50 Japan
FIG. 51 Japan market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 52 China
FIG. 53 China. market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 54 India
FIG. 55 India market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 56 Australia
FIG. 57 Australia market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 58 South Korea
FIG. 59 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 60 Latin America
FIG. 61 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 62 Brazil
FIG. 63 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 64 Mexico
FIG. 65 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 66 Argentina
FIG. 67 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 68 MEA
FIG. 69 MEA market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 70 South Africa
FIG. 71 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 72 Saudi Arabia
FIG. 73 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 74 UAE
FIG. 75 UAE market estimates and forecast, 2018 - 2030 (USD Million)
FIG. 76 Ansoff Matrix
FIG. 77 Strategy mapping
FIG. 78 Company market share analysis, 2021
FIG. 79 Heat map analysis
FIG. 80 Market differentiators
FIG. 81 Heat map analysis
FIG. 82 Regional network map

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon